Porphyrin Uptake in Lung Cancer Cells by Dynamin-Mediated Endocytosis: a Novel Marker of Dysregulated Endocytosis in Cancer. Poster, International Society for Advancement of Cytometry CYTO 2020, August 4-5, 2020

DECEMBER 14, 2015 Poster presented by David Elzi, PhD The University of Texas Health Science Center San Antonio Dr. Elzi is a member of the research collaboration team from the UT Health Science Center and bioAffinity Technologies. American Society for Cell...

Maria Zannes Talks to CEO/CFO Magazine

DECEMBER 2, 2015 As published in the CEO/CFO Magazine Interview conducted by: Lynn Fosse, Senior Editor, CEO/CFO Magazine, Published – November 30, 2015 CEO/CFO: Ms. Zannes, would you tell us the overall vision at bioAffinity Technologies? Ms. Zannes: bioAffinity...

Three questions with BioAffinity CEO Maria Zannes

OCTOBER 23, 2015 As published in the San Antonio Business Journal By W. Scott Bailey Reporter/Project Coordinator San Antonio Business Journal San Antonio’s bioAffinity Technologies was invited to present its novel technology for the detection and diagnosis of...

A Message from bioAffinity Technologies

OCTOBER 4, 2015 By Maria Zannes, President & Chief Executive Officer (SAN ANTONIO, TX ) Early detection of cancer prolongs life. Each of us at bioAffinity Technologies has seen this firsthand. Our brothers, sisters, parents, friends and patients, and many of us...

Internal Validation Research Trial

Internal Validation Research Trial February 1, 2015 27 sputum samples: 15 lung cancer sputum samples and 12 sputum samples from patients without lung cancer, December, 2008 AuthorsT. Bauer II, MD, Helen F. Graham Cancer Center; D. Merrick, MD, Denver VA Medical...